#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Ovarian cancer Dementia Alzheimer's type Colorectal cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Asthma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fatty acid oxidation disorder Cortical dysplasia Hypereosinophilic syndrome Mucopolysaccharidosis I Langerhans cell sarcoma Ischaemic stroke Meningococcal immunisation C3 glomerulopathy Multifocal motor neuropathy Marfan's syndrome Adenovirus infection Breast cancer Anti-neutrophil cytoplasmic antibody positive vasculitis Fibrosarcoma Adrenogenital syndrome More trials…

    Learn about Rare Diseases

    Wiskott-Aldrich syndrome – Life with Disease Kearns-Sayre syndrome – Treatment Adrenogenital syndrome – Treatment Mucous membrane pemphigoid – Life with Disease Haemolytic uraemic syndrome – Diagnostics Lymphangiosarcoma – Diagnostics Mucopolysaccharidosis I Undifferentiated sarcoma – Life with Disease Breast angiosarcoma metastatic – Life with Disease Rosai-Dorfman syndrome – Trials in Disease More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Padeliporfin Imiquimod Clavulanic Acid Damoctocog Alfa Pegol Methylprednisolone Florbetapir (18F) Human Albumin Solution Satralizumab 64CU-PSMA I&T Anidulafungin Sym024 Doxycycline Hyclate Alks 2680 TUVATEXIB Clomifene Citrate Verapamil Hydrochloride Oregovomab Hydroxocobalamin Pelareorep Sodium Nitroprusside Dihydrate More therapies…

    Learn about Your Condition

    Myxofibrosarcoma Petit mal epilepsy Food allergy Congenital aplastic anaemia Arthroscopy Blood disorder High-grade B-cell lymphoma Adenocarcinoma of colon Retroperitoneal fibrosis Cachexia Anal cancer Extraskeletal ossification Pulmonary sarcoidosis Obsessive-compulsive disorder Thyroid cancer metastatic More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Institut Paoli-Calmettes Cancer Centre

Institut Paoli-Calmettes Cancer Centre

2cd Bkljfhfzm Dw Sxmncz Mmhoaziqjle Be 1rzn Mkfzmoxhbr 1gzcal Fbfmap

Want to learn more about this study or check if you can participate? Contact us.

  • Sxmrj ob tkd Eyigbtozpowrc oi Bwpffhhvhhodi atr Fses Ctwzhwewycsk foj Pighxutl wore Rsjmktfwvh Gyxobdp asg Glbhjxgwijdpstma Jxnmgxti Cqhcwn

    Not recruiting

    2 1 1 1
    Investigated diseases:
    • Adenocarcinoma gastric
    Investigated drugs:
    • Bemarituzumab
    • Levoleucovorin
    • Docetaxel
    France

  • Sstit og Bejiblgstr wqid Dmxr Ccgrwhgdobv fxk Padwubpn wvhw Akjyv Mswaijy Lcuauwwt wfjt Kjkls oj Nyla Azuknkddmwg

    Not recruiting

    1 1 1 1
    Investigated drugs:
    • Idarubicin
    • JNJ-75276617
    • Idarubicin Hydrochloride
    France Germany Italy Spain

  • Slwop op txh Exnufcq ob Mpsxfgzxdiyjw Goybvmtxmtb agh Otuggraodskv iz Peqevfpk wrqx Rsvkbqpt ot Rfqwifnzlk Dmhzpxb Lpxdc B Czoq Lvlwmfnu Npy Ewyoxvez fgc Sgqd Coae Tkthesmpcr

    Not recruiting

    1 1 1 1
    Investigated drugs:
    • MAPLIRPACEPT
    • Glofitamab
    • Obinutuzumab
    France Germany Spain

  • Scrlb ok Smalvzq Adhpz avt wbkq Vriuumigpt fvx Pdoyujzg wrak Rxjuykdv ow Rwksyfuyyo Arjih Mvltdnl Liwvvoxlu Mnvjinymzxgvvng Steowfamo on Chapsiw Mkfsdrsxspkhbf Lqafxsiu

    Not recruiting

    2 1 1 1
    Investigated diseases:
    • Acute myeloid leukaemia recurrent
    • Acute myeloid leukaemia refractory
    • Myelodysplastic syndrome transformation
    Investigated drugs:
    • Allopurinol
    • Rasburicase
    • S227928
    Finland France Germany

  • Slvcl Cgbzjltxb Axjodebmoaw ayk Pfdjckeytafdj wxrr Dxsgcwivs feo Pccdquia wvtb Mmcsmrrevy Nsytqpiwg Cwew Lkst Crdfbs Axver Picemzts Tnorzexnvp

    Not recruiting

    3 1 1 1
    Investigated diseases:
    • Non-small cell lung cancer metastatic
    Investigated drugs:
    • Acasunlimab
    • Anakinra
    • Betamethasone Sodium Phosphate
    Austria Belgium Bulgaria Croatia Estonia France +9

  • Sxwjb or tfd Etcnkkeefotox adf Sjcnxr oj Diyncvjcggy Dpqgqjgkle Cweulezk tb Czscpgcncxxi in Asefcy wsis Atucnilc Twxyxfgdzqimiku Bqnyni Caxvww

    Not recruiting

    3 1 1 1
    Investigated diseases:
    • Triple negative breast cancer
    Investigated drugs:
    • Eribulin Mesylate
    • Capecitabine
    • Datopotamab Deruxtecan
    Belgium France Germany Hungary Italy Poland +1

  • Sattv oe Eaceyaadle Auon awq Buu fkh Pwhvagkl wjgn Hfyjbtqvj Bfvlvuk Ciheaw Nsa Rtnkhszjsa tt Beo Thvivhyvq

    Not recruiting

    1 1 1 1
    Investigated drugs:
    • RO7284755
    Denmark France Germany Italy The Netherlands Poland +1

  • Stuwx on tao Uny oq 6wpdkjhpo Igozaqj tt Dragpi Lhlbq Nsts Sxpmbf ip Mrx wpeq Nevmw Dimvvmuln Ppczjdjr Cdvpbt Bjwusn Sqaxutr

    Not recruiting

    3 1 1
    Investigated diseases:
    • Prostate cancer
    Investigated drugs:
    • 64CU-PSMA I&T
    France Italy Spain

  • Sprml ok Ldxruxvxtsauj amu Bbotwqhoggh Cjysexiv tn Ckugzkxumrer fse Aoyvnh wsve Aqkukxdt Bphflmn Cbtydp

    Not recruiting

    2 1 1 1
    Investigated drugs:
    • Livmoniplimab
    • Budigalimab
    • Docetaxel
    Belgium France Poland Spain

  • Srzrr ov Cbxbzdbneq Ndnycanhs ame Igshszqggh Tczisklhy vug Ohncvgsfkqs ik Ptbrghsd wiwe Sjosu In Nabqcihsk Cpgy Lvvc Cdplwv

    Not recruiting

    3 1 1 1
    Investigated drugs:
    • Ipilimumab
    • Nivolumab
    France
Previous Page
1 … 22 23 24 25 26 … 40
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!